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A B S T R A C T
Ictal asystole is a presumably rare but potentially fatal complication of seizures, most often of temporal
lobe origin. It is believed that at least some cases of sudden unexplained death in epilepsy (SUDEP) might
be triggered by ictal bradycardia or asystole. Current standard practice is to implant a permanent
pacemaker in these patients to prevent syncope and/or death. However, emerging data suggests that
effective medical or surgical treatment of epilepsy might be enough to prevent cardiac asystole,
eliminating the need for permanent pacemaker placement. We describe a case of new onset left frontal
lobe epilepsy in a young athletic patient who presented with near-syncopal episodes but whose
comprehensive work-up revealed frequent events of ictal bradycardia and asystole. He responded well
to monotherapy using oxcarbazepine, avoiding a permanent pacemaker.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Ictal bradycardia and asystole are rare but serious complica-
tions of seizures, most often associated with temporal lobe
epilepsy.1,2 They are believed to represent autonomic dysfunction
triggered by ictal discharges involving the insula, amygdala,
cingulate, or hypothalamus.1–4 Although ictal asystole has been
reported to be self-limited in most cases,1 it is widely theorized
that sudden unexplained death in epilepsy (SUDEP) might be
caused, or contributed to, by ictal bradycardia or asystole. Other
speculated mechanisms for SUDEP include ictal respiratory
depression, cerebral depression, and autonomic dysfunction.5
Since the incidence of SUDEP has been estimated from 1% to
12% of epilepsy patients, it is important that any potential
preventive measures be explored.6 Most reported cases of ictal
asystole seem to have had permanent pacemaker placement given
the potentially lethal nature of the underlying arrhythmia and the
fear for potential future SUDEP.7 However, there is emerging data
in favor of medical or surgical treatment of epilepsy to prevent ictal
asystole and thus avoid permanent pacemaker placement. We
describe a young athletic patient with new onset left frontal lobe
epilepsy presenting with near-syncopal episodes whose compre-* Corresponding author at: Department of Neurology, PHC 7, Georgetown
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dia and asystole. He became seizure free on monotherapy with
oxcarbazepine.
2. Case report
A 38-year-old healthy male kickboxer presented with four brief
near-syncopal episodes in the setting of aggressive athletic training,
dieting and possible dehydration. The episodes were described as
several seconds of staring with loss of awareness but without any
abnormal motor activity or falls and a recovery free of confusion. He
denied palpitations, chest pain and shortness of breath, but reported
lightheadedness and a ‘‘weird sensation’’ immediately before and
after each episode. A work-up by a local neurologist including head
CT, brain MRI, and 24-h ambulatory EEG were normal. He was
referred to our epilepsy center for further evaluation after he
experienced a fourth episode, all within a month.
The patient was admitted to the epilepsy monitoring unit
(EMU) to attempt to determine if the events were seizures or near-
syncope. Scalp EEG electrodes were placed according to partial 10–
10 electrode system for extra coverage of temporal and frontal
areas. Continuous cardiac telemetry was included as part of our
routine EMU procedures. He was not on any antiepileptic drugs
before or during the recording. His baseline EEG was normal with
no epileptiform discharges.
On the second day of monitoring he had three stereotyped
partial onset seizures within a 12-h period while awake and lying
supine in bed. Clinically, these seizures consisted of eye deviationvier Ltd. All rights reserved.
Fig. 1. Two, side by side, consecutive standard 10 s EEG traces (A and B) recorded using partial 10–10 electrode system (top panel) with magniﬁed view of the top 8 leads
(bottom panel). Buildup of semirhythmic theta (ictal) discharges in the left fronto-temporal leads (arrow) precedes bradycardia by 1–2 s. The ictal discharges continue in
fronto-temporal leads, max frontal, with no clinical signs. The start of asystole is recorded on the EKG lead about 12 s later (top panel).
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left arm remaining in a frozen contraction–extension posture for
about 5–15 s before a rapid and full recovery. The EEG associated
with these events consistently showed a semirhythmic theta
activity in the left anterior head regions lasting for about 8–20 s
(Fig. 1) followed by a 3–10-s burst of diffuse delta slow activity,
after which the EEG normalized (Fig. 2A). Both telemetry and the
EKG lead on the EEG trace detected a progressively marked
bradycardia upon the start of the epileptiform discharges that
quickly evolved into complete asystole lasting for 22.5, 8.5 and
24.5 s with each seizure, respectively, before a return of
spontaneous rhythm (Fig. 2B). The ending of each asystolic
episode coincided with delta diffuse slowing on the EEG.
Immediately after the events the patient was awake and
oriented. He was able to push the event button and report a ‘‘spell’’
described as ‘‘lightheadedness’’, ‘‘funny feeling’’, and ‘‘possibly a
brief loss of awareness’’. There were no other documented episodes
of asystole in between these seizures. These symptoms and EEG
ﬁndings were most suggestive of a left frontal lobe seizure.
Cardiology was consulted for management of the asystolic
episodes and possible permanent pacemaker insertion. A 2D
echocardiogram demonstrated normal left ventricular size, thick-
ness and systolic function, with an ejection fraction of 55%. The
possibility of a permanent pacemaker including the risks, beneﬁts
and alternatives were discussed by the management team but
deferred by the patient as it would interfere with his active lifestyle,
particularly kickboxing. Further, backup pacing might have had the
unintended consequence of preventing seizure termination. It has
been theorized that global cerebral hypoperfusion, as manifested
by bilateral hypersynchronous EEG slowing, plays a role in ending
seizure discharges.2 It seemed clear that the asystole was directly
connected to inciting ictal discharges. Therefore, on the third day
of admission he was started on the antiepileptic drug lamotrigine,
but given the possibility of inducing conduction block, it was
switched to oxcarbazepine at 150 mg twice a day (bid) to be
titrated up weekly. He had no recurrences of either seizure activity
or asystole during the remaining 48 h of monitoring.
The patient also had a two-week outpatient EKG telemetry
monitoring within one month of hospital discharge, which showedno episodes of bradycardia or pauses as he remained seizure free
during that time on medication. Two months later he reported two
seizures both associated with loss of consciousness and falls; it
remained uncertain whether he had any related asystole or not.
The oxcarbazepine dose was increased from 450 mg bid to 600 mg
bid, and after a further loss of consciousness 4 months later, to
750 mg bid. He has remained seizure free on this dose since then
(last 6 months). His follow up brain MRI was normal.
3. Discussion
While the long-term beneﬁts of cardiac pacing in preventing
falls in patients with ictal asystole has been established8 our
experience with this patient suggests that effective medical
therapy to control seizures might be enough to avoid permanent
pacemaker insertion. In fact, most recently Strzelczyk et al. have
reviewed 15 patients with ictal asystole or bradycardia, all with
temporal lobe seizures, and proposed that in patients who achieve
seizure freedom through medical or surgical therapy, ictal asystole
may no longer be a risk thus obviating the need for cardiac
pacemaker implantation. Our patient’s excellent response to
medical therapy and seizure freedom is further supportive of this
approach.
This patient also had several other features that are heretofore
uncommon in the described cases of ictal asystole, underscoring
potential limitations in our current understanding and areas for
possible research. Ictal asystole is often noted in patients with
chronic refractory temporal lobe epilepsy.1 Our patient is unique
as he represents a new onset seizure disorder presenting with ictal
asystole. Also, the incidence of frontal lobe seizures appearing as a
case of near-syncope, thus obscuring the diagnosis of seizure and
asystole, is rare. It is to be noted that ictal asystole is not
extensively described in cardiac electrophysiology literature. This
case raises the possibility of more undetected cases of ictal
asystole of frontal lobe origin, where quite often ictal EEG
discharges are undetectable on scalp recording. Our patient was in
a seated or supine position at the time of his ﬁrst few seizures,
preventing collapse, which he in fact had after hospital discharge
with later episodes. Had he collapsed with these initial episodes,
Fig. 2. Diffuse delta slow activity more pronounced on the left, as well as lower voltage faster discharges in the left fronto-temporal head regions are present towards the end
of the prolonged asystole (A), before the normal cardiac rhythm returns (arrow). The start and end of asystole is recorded on the cardiac telemetry strip (B).
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syncope and potentially delayed the diagnosis of epilepsy.
Moreover, such cases could easily be misdiagnosed by a non-
neurologist as asystole-induced brain anoxia with secondarily
triggered seizures, which would further delay appropriate
therapy.
This case also points out the importance of cardiac telemetry as
part of epilepsy monitoring since the EKG lead used as part of EEG
recording would not trigger an alarm in case of asystole.
We propose including cardiac telemetry and pulse oximetry
during epilepsy monitoring as affordable safety measures to
minimize the risk of missing cardiac or respiratory arrest, which –
as this case highlights – can be caused even by subtle seizures that
might not be detected based on EEG or clinical presentation alone.
Finally, initiating antiepileptic drugs and achieving seizure
freedom in ictal asystole could also minimize the risk of SUDEP,
which remains an obscure and lethal complication of epilepsy.References
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